drugset / Trial / NCT03360760
Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum
RandomizedSingle-groupOpen-labelTreatment
Summary
To study the effect of the timing of surgery on outcome of patients with nonmetastatic osteosarcoma of pelvis and sacrum.
Timeline
- Start
- 2018-08-01
- Primary completion
- 2020-02
- Completion
- 2025-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cisplatin | Other / unclassified | 100 mg/m2 | — |
| Background | Doxorubicin | Other / unclassified | 60 mg/m2 | — |
| Background | Ifosfamide | Small molecule | 12 g | — |
| Background | Methotrexate | Small molecule | 8 g | — |
| Background | Methotrexate | Small molecule | 12 g | — |